A clinical trial for chemotherapy induced peripheral neuropathy has begun, with the first patient dosed. The trial's details and sponsors are not entirely clear, with multiple companies and studies mentioned in relation to the condition. Research into chemotherapy induced peripheral neuropathy is ongoing, with various studies examining potential predictors and preventions, including vitamin D levels.